Compare ARK Genomic Revolution ETF (ARKG) vs Lufax Holding Ltd (LU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Lufax Holding Ltd — how do they compare? ARK Genomic Revolution ETF trades at $40.88, while Lufax Holding Ltd trades at $1.25 (market cap $2.41B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Lufax Holding Ltd nearer its low. Which is the better fit depends on your goals.
| ARKG | LU | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $4.40 |
52-Week Low | $23.09 | $1.23 |
Market Cap | — | $2.41B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
LU trades at $1.34, down 1.47% today, with a neutral technical signal and bearish moving averages. The company reported 2025 revenue of $23.1B but a net loss of $2.1B, with negative profit margins. Analyst consensus is 62% buy, but recent news highlights multiple class-action lawsuits filed against the company, creating significant legal overhangs. Cash flow trends show negative net cash flow of $709M in 2025, driven by heavy investing outflows.
The outlook is mixed: low valuation ratios (P/S 0.34, P/B 0.1) suggest potential upside if profitability improves, but persistent losses, legal risks, and negative cash flow pose substantial downside risks. Investors should weigh cheap valuation against execution challenges and litigation uncertainties in the near term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Lufax Holding Ltd
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →
